Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

NUS study offers new hope for treating aggressive ovarian cancer subtype

A recent discovery by researchers from the Cancer Science Institute of Singapore at the National University of Singapore may lead to a new treatment strategy for an aggressive ovarian cancer subtype.

30 Nov 2016

Scientists develop easy-to-use software tool to detect important genetic mutations

Scientists have developed an easy-to-use software tool that can detect important genetic mutations that previously needed to be identified by a separate test.

29 Nov 2016

Testing for Lynch syndrome: an interview with Kevin Monahan

Lynch syndrome is an inherited condition which causes about 1,100 cases of bowel cancer and 1,000 other cancers annually in the UK. It is caused by a fault in the mismatch repair gene (MMR) which usually works to prevent cancer.

21 Nov 2016

Scientists develop new computer-based method to assess cell communication networks

A multi-institution academic-industrial partnership of researchers led by Case Western Reserve University School of Medicine has developed a new method to broadly assess cell communication networks and identify disease-specific network anomalies.

8 Nov 2016

New treatment with therapeutic short interfering RNA could help thwart cancer

In the fight against cancer, doctors dish out combination-blows of surgery, chemotherapy and other drugs to beat back a merciless foe. Now, scientists have taken early steps toward adding a stinging punch to clinicians' repertoire.

7 Nov 2016

Long-term weight gain may increase risk of obesity-related cancers

Substantial weight gain over many years increases the risk of obesity-related cancers in men by 50 per cent and in women by almost 20 per cent, according to new research presented at the National Cancer Research Institute's Cancer Conference in Liverpool, today (Monday).

6 Nov 2016

Combination treatment can reduce tumor's resistance to chemotherapy in ovarian cancer

Treating ovarian cancer with platinum-based chemotherapy drugs such as cisplatin is initially very effective, with about four out of five patients responding favorably. However, most of these patients quickly become resistant to chemotherapy and may not respond as well to this standard treatment for the disease.

1 Nov 2016

Researchers identify protein linked to negative effects of senescence

Cellular senescence is a state in which normal healthy cells do not have the ability to divide. Senescence can occur when cancer-causing genes are activated in normal cells or when chemotherapy is used on cancer cells.

1 Nov 2016

Scientists discover how MEK inhibitor boosts antitumor activity and slows cancer progression

Understanding the effects of certain targeted therapies on antitumor immunity is necessary to design combined interventions for more effective cancer treatment.

1 Nov 2016

Research findings may lead to new treatment option for ovarian cancer

A new study has identified an effective combination therapy for treating ovarian cancer cells.

31 Oct 2016

Scientists find new way to see where certain cancer drugs accumulate in the body

Nanomedicine has the potential to help personalize cancer treatments and reduce side effects of therapeutic drugs.

26 Oct 2016

Scientists discover new option for treating malignant pleural mesothelioma

Researchers at the Comprehensive Cancer Center of MedUni Vienna and Vienna General Hospital have discovered a new option for treating malignant pleural mesothelioma.

24 Oct 2016

Natural compound isolated from onions contains anti-ovarian cancer properties, research finds

Research from Kumamoto University, Japan has found that a natural compound isolated from onions, onionin A (ONA), has several anti-ovarian cancer properties.

20 Oct 2016

Research could lead to new type of treatment for pancreatic cancer based on gold nanoparticles

A diagnosis of pancreatic cancer is often a death sentence because chemotherapy and radiation have little impact on the disease.

19 Oct 2016

Financial difficulties may impact treatment outcomes for cancer patients

Financial difficulties can significantly impact a cancer patient's quality of life during treatment and may even increase their risk of death, according to the results of a pooled analysis presented at the ESMO 2016 Congress in Copenhagen.

12 Oct 2016

PARP inhibitor prolongs progression-free survival in patients with recurrent ovarian cancer

The PARP inhibitor niraparib significantly improves the outcome of platinum-sensitive recurrent ovarian cancer, according to full data from the ENGOT-OV16/NOVA trial presented for the first time at the ESMO 2016 Congress in Copenhagen and published in the New England Journal of Medicine.

8 Oct 2016

Unique partnership develops web-based resource addressing issues in gynecologic cancers

In order to help families benefit from precision medicine, several professional medical organizations and patient advocacy groups have collaborated to develop a resource for healthcare providers and patients concerned with gynecologic cancers.

5 Oct 2016

HDAC inhibitors show potential to eliminate breast and ovarian cancer stem cells

A group of researchers, led by scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, has shown that histone deacetylase (HDAC) inhibitors have the potential to eliminate stubborn reservoirs of breast and ovarian cancer stem cells (CSCs).

4 Oct 2016

Research shows how new ovarian cancer treatment could help boost anti-tumor immunity

Few effective treatments have been approved to treat ovarian cancer, the deadliest of all cancers affecting the female reproductive system.

3 Oct 2016

HPV vaccine can decrease incidence of cervical pre-cancers among young women, research shows

Every 20 minutes, someone in the United States receives a cancer diagnosis related to human papillomavirus. HPV causes cancer of the cervix, anus and throat.

29 Sep 2016

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

NUS study offers new hope for treating aggressive ovarian cancer subtype

Scientists develop easy-to-use software tool to detect important genetic mutations

Testing for Lynch syndrome: an interview with Kevin Monahan

Scientists develop new computer-based method to assess cell communication networks

New treatment with therapeutic short interfering RNA could help thwart cancer

Long-term weight gain may increase risk of obesity-related cancers

Combination treatment can reduce tumor's resistance to chemotherapy in ovarian cancer

Researchers identify protein linked to negative effects of senescence

Scientists discover how MEK inhibitor boosts antitumor activity and slows cancer progression

Research findings may lead to new treatment option for ovarian cancer

Scientists find new way to see where certain cancer drugs accumulate in the body

Scientists discover new option for treating malignant pleural mesothelioma

Natural compound isolated from onions contains anti-ovarian cancer properties, research finds

Research could lead to new type of treatment for pancreatic cancer based on gold nanoparticles

Financial difficulties may impact treatment outcomes for cancer patients

PARP inhibitor prolongs progression-free survival in patients with recurrent ovarian cancer

Unique partnership develops web-based resource addressing issues in gynecologic cancers

HDAC inhibitors show potential to eliminate breast and ovarian cancer stem cells

Research shows how new ovarian cancer treatment could help boost anti-tumor immunity

HPV vaccine can decrease incidence of cervical pre-cancers among young women, research shows

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in